Trial Outcomes & Findings for A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System (NCT NCT02184520)
NCT ID: NCT02184520
Last Updated: 2021-03-15
Results Overview
The study was terminated prior to primary and secondary endpoint data collection, therefore no study data is reported.
TERMINATED
NA
1 participants
24 months
2021-03-15
Participant Flow
The study was terminated prior to primary and secondary endpoint data collection, therefore no study data is reported.
Participant milestones
| Measure |
TRANSITION
Stabilization System
TRANSITION
|
REVERE
Stabilization System
REVERE
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 24 monthsPopulation: The study was terminated prior to primary and secondary endpoint data collection, therefore no study data is reported.
The study was terminated prior to primary and secondary endpoint data collection, therefore no study data is reported.
Outcome measures
Outcome data not reported
Adverse Events
TRANSITION
REVERE
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results.
- Publication restrictions are in place
Restriction type: OTHER